• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾移植患者血浆泼尼松龙浓度及动力学

Plasma prednisolone concentrations and kinetics in renal transplant patients.

作者信息

Nelson W E, Doherty C C, Douglas J F, McGeown M G, Delargy H, Temple D J

出版信息

Proc Eur Dial Transplant Assoc. 1983;19:544-51.

PMID:6348752
Abstract

Plasma prednisolone concentrations were measured in 26 renal transplant (RT) patients and five control subjects. A linear relationship was found between prednisolone dosage in mg/kg and area under the plasma concentration time curve in seven stable RT patients (r = 0.98) and in all subjects (n = 19) with estimated prednisolone clearance rates (CLp) between 0.075 and 0.11 L/kg/hr (r = 0.96). The greatest deviation from this occurred in five patients having reduced CLp with prolonged prednisolone half life (t1/2p) and in one having increased CLp while taking phenytoin. Three of the five with reduced clearance had steroid induced diabetes and one a Cushingoid appearance. There was some correlation between peak plasma prednisolone and dosage (r = 0.77) in all subjects, but none between creatinine clearance and t1/2p or CLp.

摘要

对26例肾移植(RT)患者和5名对照受试者的血浆泼尼松龙浓度进行了测量。在7例病情稳定的RT患者中,发现泼尼松龙剂量(mg/kg)与血浆浓度-时间曲线下面积之间存在线性关系(r = 0.98);在所有估计泼尼松龙清除率(CLp)介于0.075至0.11 L/kg/hr之间的受试者(n = 19)中也存在这种关系(r = 0.96)。这种关系的最大偏差出现在5例CLp降低且泼尼松龙半衰期(t1/2p)延长的患者中,以及1例服用苯妥英钠时CLp增加的患者中。5例清除率降低的患者中有3例患有类固醇诱导的糖尿病,1例有库欣样外观。在所有受试者中,血浆泼尼松龙峰值与剂量之间存在一定相关性(r = 0.77),但肌酐清除率与t1/2p或CLp之间无相关性。

相似文献

1
Plasma prednisolone concentrations and kinetics in renal transplant patients.肾移植患者血浆泼尼松龙浓度及动力学
Proc Eur Dial Transplant Assoc. 1983;19:544-51.
2
Different prednisolone pharmacokinetics in Cushingoid and non-Cushingoid kidney transplant patients.库欣样和非库欣样肾移植患者中泼尼松龙的药代动力学差异。
Proc Eur Dial Transplant Assoc. 1983;20:286-90.
3
Effect of plasma lipid on pharmacokinetics of ciclosporin and its relationship with plasma prednisolone level in renal transplant patients.血浆脂质对肾移植患者环孢素药代动力学的影响及其与血浆泼尼松龙水平的关系。
J Pharm Pharmacol. 2006 Sep;58(9):1193-200. doi: 10.1211/jpp.58.9.0005.
4
Disappearance of high dose prednisolone from plasma after renal transplantation.肾移植后高剂量泼尼松龙从血浆中的消失情况。
Clin Nephrol. 1974 Jan-Feb;2(1):18-23.
5
Three-years experience with Neoral C2 monitoring adjusted to a target range of 500-600 ng/ml in long-term renal transplant recipients receiving dual immunosuppressive therapy.在接受双重免疫抑制治疗的长期肾移植受者中,使用新山地明C2监测并调整至500 - 600 ng/ml目标范围的三年经验。
Scand J Urol Nephrol. 2008;42(3):286-92. doi: 10.1080/00365590701748039.
6
Prednisolone pharmacokinetics in cushingoid and non-cushingoid kidney transplant patients.库欣样和非库欣样肾移植患者中泼尼松龙的药代动力学
Kidney Int. 1985 Feb;27(2):459-64. doi: 10.1038/ki.1985.31.
7
Relationship between area under the concentration versus time curve of cyclosporin A, creatinine clearance, hematocrit value, and other clinical factors in Japanese renal transplant patients.日本肾移植患者中环孢素A浓度-时间曲线下面积、肌酐清除率、血细胞比容值及其他临床因素之间的关系。
Int J Clin Pharmacol Ther. 1998 Apr;36(4):202-9.
8
Prednisolone disposition in cushingoid and noncushingoid kidney transplant patients.库欣样和非库欣样肾移植患者体内泼尼松龙的处置情况。
J Clin Endocrinol Metab. 1980 Sep;51(3):561-5. doi: 10.1210/jcem-51-3-561.
9
Pharmacokinetics of mycophenolic acid during the early period after renal transplant.肾移植术后早期霉酚酸的药代动力学
Exp Clin Transplant. 2007 Dec;5(2):658-63.
10
Pharmacokinetic study of the combination of tacrolimus and fluconazole in renal transplant patients.肾移植患者中他克莫司与氟康唑联合应用的药代动力学研究。
J Med Assoc Thai. 2006 Aug;89 Suppl 2:S73-8.

引用本文的文献

1
Prednisolone protein binding in renal transplant patients.肾移植患者中泼尼松龙的蛋白结合情况。
Br J Clin Pharmacol. 1985 Aug;20(2):159-62. doi: 10.1111/j.1365-2125.1985.tb05050.x.